Pracinostat (SB-939)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 01:58, 26 April 2022 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

HDAC inhibitor

History of changes in FDA indication

2/27/2014: Granted FDA orphan drug status for treatment of acute myeloid leulemia.

Also known as

Code name: SB939

Retrieved from "https://hemonc.org/w/index.php?title=Pracinostat_(SB-939)&oldid=55781"